Darifenacin hydrobromide and Joint swelling - a phase IV clinical study of FDA data

Summary:

Joint swelling is reported as a side effect among people who take Darifenacin hydrobromide (darifenacin hydrobromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Enbrel, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Joint swelling when taking Darifenacin hydrobromide. It is created by eHealthMe based on reports of 511 people who have side effects when taking Darifenacin hydrobromide from the FDA, and is updated regularly.

What is Darifenacin hydrobromide?

Darifenacin hydrobromide has active ingredients of darifenacin hydrobromide. eHealthMe is studying from 512 Darifenacin hydrobromide users. Check the latest studies of Darifenacin hydrobromide.

What is Joint swelling?

Joint swelling is found to be associated with 2,123 drugs and 2,934 conditions by eHealthMe. Check the latest studies of Joint swelling.

On Jul, 06, 2026

511 people reported to have side effects when taking Darifenacin hydrobromide.
Among them, 141 people (27.59%) have Joint swelling.

Could Darifenacin hydrobromide cause Joint swelling?

Among these 141 people:

How long have people been on Darifenacin hydrobromide when they have Joint swelling? *

Click here to view more results

What is the gender of people who have Joint swelling when taking Darifenacin hydrobromide? *

Click here to view

What is the age of people who have Joint swelling when taking Darifenacin hydrobromide? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Darifenacin hydrobromide and have Joint swelling?

- Check whether Joint swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Darifenacin hydrobromide:

Darifenacin hydrobromide (512 reports)

Joint swelling treatments and more:

Joint swelling (143,797 reports)

How severe was Joint swelling and when was it recovered:

Joint swelling in Darifenacin hydrobromide

Expand to all the drugs that have ingredients of darifenacin hydrobromide:

Joint swelling and drugs with ingredients of darifenacin hydrobromide (280 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Darifenacin hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint swelling:

Joint swelling (2,123 drugs)

Browse all the conditions that are associated with Joint swelling:

Joint swelling (2,934 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on darifenacin hydrobromide (the active ingredients of Darifenacin hydrobromide) and Darifenacin hydrobromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.